Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition

Virology

Volumn 402, Issue 1, 2010, Pages 215-221

  Somboonthum, Pranee ^a   Koshizuka, Tetsuo ^a   Okamoto, Shigefumi ^a   Matsuura, Masaaki ^a,c   Gomi, Yasuyuki ^c   Takahashi, Michiaki ^c   Yamanishi, Koichi ^a   Mori, Yasuko ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Osaka University   (Japan)

Author keywords

Site specific transposition; Tn7; Vaccine; VOka; VZV

Indexed keywords

CHICKENPOX VACCINE; HYBRID PROTEIN; LIVE VACCINE; RECOMBINANT VACCINE; VIRUS VECTOR; VIRUS FUSION PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; DNA TRANSPOSITION; EXPRESSION VECTOR; GENE CASSETTE; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPOSON; VARICELLA ZOSTER VIRUS; VIRUS GENOME; VIRUS RECOMBINANT; ANIMAL; CELL LINE; CERCOPITHECUS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETICS; GUINEA PIG; METHODOLOGY; VIRUS CULTURE; VIRUS LOAD;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 3; MUMPS VIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CHICKENPOX VACCINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA TRANSPOSABLE ELEMENTS; GENETIC ENGINEERING; GENETIC VECTORS; GUINEA PIGS; MUTAGENESIS, INSERTIONAL; PLAQUE ASSAY; RECOMBINATION, GENETIC; VIRAL FUSION PROTEINS; VIRAL LOAD;

EID: 77952558438     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.03.032     Document Type: Article

References (35)

1. Arvin A.M. Varicella-zoster virus. Clin. Microbiol. Rev. 1996, 9(3):361-381.
2. Arvin A.M. Varicella vaccine: genesis, efficacy, and attenuation. Virology 2001, 284(2):153-158.
3. Arvin A.M., Greenberg H.B. New viral vaccines. Virology 2006, 344(1):240-249.
4. Barth P.T., Datta N., Hedges R.W., Grinter N.J. Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons. J. Bacteriol. 1976, 125(3):800-810.
5. Chaves S.S., Haber P., Walton K., Wise R.P., Izurieta H.S., Schmid D.S., Seward J.F. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J. Infect. Dis. 2008, 197(Suppl 2):S170-S177.
6. Cohen J.I., Starus S.E., Arvin A.M. Varicella-zoster virus replication, pathogenesis, and management. Fields Virology 2007, 2773-2818. Lippincott-Williams & Wilkins, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
7. Galea S.A., Sweet A., Beninger P., Steinberg S.P., Larussa P.S., Gershon A.A., Sharrar R.G. The safety profile of varicella vaccine: a 10-year review. J. Infect. Dis. 2008, 197(Suppl 2):S165-S169.
8. Gershon A.A., Steinberg S.P., Gelb L., Galasso G., Borkowsky W., LaRussa P., Farrara A. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 1984, 252(3):355-362.
9. Hahn G., Jarosch M., Wang J.B., Berbes C., McVoy M.A. Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction. J. Virol. Methods 2003, 107(2):185-194.
10. Heineman T.C., Connelly B.L., Bourne N., Stanberry L.R., Cohen J. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J. Virol. 1995, 69(12):8109-8113.
11. Hishiyama M., Tsurudome M., Ito Y., Yamada A., Sugiura A. Complement-mediated neutralization test for determination of mumps vaccine-induced antibody. Vaccine 1988, 6(5):423-427.
12. Houard S., Varsanyi T.M., Milican F., Norrby E., Bollen A. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. J. Gen. Virol. 1995, 76(Pt 2):421-423.
13. Kamiya H., Kato T., Isaji M., Torigoe S., Oitani K., Ito M., Ihara T., Sakurai M., Takahashi M. Immunization of acute leukemic children with a live varicella vaccine (Oka strain). Biken J. 1984, 27(2-3):99-102.
14. Koshizuka T., Sadaoka T., Yoshii H., Yamanishi K., Mori Y. Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells. Virology 2008, 377(2):289-295.
15. Kubo K.M., Craig N.L. Bacterial transposon Tn7 utilizes two different classes of target sites. J. Bacteriol. 1990, 172(5):2774-2778.
16. Lalioti M., Heath J. A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli. Nucleic Acids Res. 2001, 29(3):E14.
17. Lichtenstein C., Brenner S. Site-specific properties of Tn7 transposition into the E. coli chromosome. Mol. Gen. Genet. 1981, 183(2):380-387.
18. Lowe R.S., Keller P.M., Keech B.J., Davison A.J., Whang Y., Morgan A.J., Kieff E., Ellis R.W. Varicella-zoster virus as a live vector for the expression of foreign genes. Proc. Natl. Acad. Sci. U.S.A. 1987, 84(11):3896-3900.
19. Luckow V.A., Lee S.C., Barry G.F., Olins P.O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 1993, 67(8):4566-4579.
20. McKown R.L., Orle K.A., Chen T., Craig N.L. Sequence requirements of Escherichia coli attTn7, a specific site of transposon Tn7 insertion. J. Bacteriol. 1988, 170(1):352-358.
21. Nagaike K., Mori Y., Gomi Y., Yoshii H., Takahashi M., Wagner M., Koszinowski U., Yamanishi K. Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine 2004, 22(29-30):4069-4074.
22. Okuno T., Yamanishi K., Shiraki K., Takahashi M. Synthesis and processing of glycoproteins of varicella-zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Virology 1983, 129(2):357-368.
23. Rogers M., Ekaterinaki N., Nimmo E., Sherratt D. Analysis of Tn7 transposition. Mol. Gen. Genet. 1986, 205(3):550-556.
24. Sadaoka T., Yoshii H., Imazawa T., Yamanishi K., Mori Y. Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J. Virol. 2007, 81(22):12654-12665.
25. Sakata H., Hishiyama M., Sugiura A. Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines. J. Clin. Microbiol. 1984, 19(1):21-25.
26. Shiraki K., Hayakawa Y., Mori H., Namazue J., Takamizawa A., Yoshida I., Yamanishi K., Takahashi M. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J. Gen. Virol. 1991, 72(Pt 6):1393-1399.
27. Shiraki K., Sato H., Yoshida Y., Yamamura J.I., Tsurita M., Kurokawa M., Kageyama S. Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen. J. Med. Virol. 2001, 64(2):89-95.
28. Somboonthum P., Yoshii H., Okamoto S., Koike M., Gomi Y., Uchiyama Y., Takahashi M., Yamanishi K., Mori Y. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine 2007, 25(52):8741-8755.
29. Takahashi M., Iketani T., Sasada K., Hara J., Kamiya H., Asano Y., Baba K., Shiraki K. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen. J. Infect. Dis. 1992, 166(Suppl 1):S58-S62.
30. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974, 2(7892):1288-1290.
31. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol. 2003, 77(2):1382-1391.
32. von Messling V., Milosevic D., Devaux P., Cattaneo R. Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function. J. Virol. 2004, 78(15):7894-7903.
33. Waddell C.S., Craig N.L. Tn7 transposition: two transposition pathways directed by five Tn7-encoded genes. Genes Dev. 1988, 2(2):137-149.
34. Wagner M., Ruzsics Z., Koszinowski U.H. Herpesvirus genetics has come of age. Trends Microbiol. 2002, 10(7):318-324.
35. Yoshii H., Somboonthum P., Takahashi M., Yamanishi K., Mori Y. Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine 2007, 25(27):5006-5012.